Genetic risk factor for clotting after COVID-19 infection

Which people who catch COVID-19 have a higher risk of
developing blood clots? A Monash-Baker study investigated.

With blood clots caused by COVID-19 already associated with a higher risk of death, it is important to understand which groups are vulnerable and how best to treat them. 

New information is emerging on COVID-associated blood clots in people with inherited thrombotic conditions such as the common Factor V Leiden, which affects about in one in every 20 or 25 people in Australia.

Congratulations to our PhD graduates, Paddy Dempsey and James McFadyen!

James McFadyen

Paddy Dempsey

Congratulations to our recent PhD graduates, James McFadyen and Paddy Dempsey!

Paddy Dempsey's thesis is titled "Interrupting Prolonged Sitting Time: Implications for Type 2 Diabetes Management”, and he completed his research in the Baker Heart and Diabetes Research Institute under the principal supervision of Dr David Dunstan and Professor Neville Owen.

James McFadyen's thesis is titled, "Investigating the mechanisms of platelet hyperactivity in diabetes mellitus”. James's supervisors were Adjunct Research Fellow Dr Yu-Ping Yuan and Adjunct Associate Professor Simone Schoenwaelder in the Australian Centre for Blood Diseases and Professor Shaun Jackson (University of Sydney).